Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: AIDS. 2021 Oct 1;35(12):1949–1956. doi: 10.1097/QAD.0000000000002981

Figure 1. Odds ratio for risk of future viremia based on 3-day self-reported adherence and emtricitabine triphosphate (FTC-TP) concentrations in dried blood spots.

Figure 1.

SR:3-day Self-Reported adherence; FTC-TP: emtricitabine triphosphate; Quant: Quantifiable; BLQ: Below the Limit of Quantification. *p-values adjusted for multiple comparisons using the Tukey-Kramer adjustment.

**Adjusted for age, age, gender, race, body mass index (BMI), estimated glomerular filtration rate (eGFR, estimated using MDRD equation), CD4+ T-cell count, hematocrit, and ART class. FTC-TP in DBS was considered BLQ if it was <0.1 pmol/sample.